Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study

Translational Vision Science & Technology
Yu YuYing Chau

Abstract

To evaluate the biocompatibility and 6-month in vivo release of bevacizumab from a hyaluronic acid/dextran-based in situ hydrogel after intravitreal injection in rabbit eye. The in situ hydrogel was formed by the catalyst-free chemical crosslinking between vinylsulfone functionalized hyaluronic acid (HA-VS) and thiolated dextran (Dex-SH) at physiological condition. The pH 7.4 buffered mixture containing HA-VS, Dex-SH, and bevacizumab were injected into the vitreous of rabbit eyes by a 30-G needle. The biocompatibility was evaluated by intraocular pressure measurement, binocular indirect ophthalmoscope (BIO), full-field electroretinogram (ERG), and histology. The concentrations of both total and active bevacizumab in rabbit vitreous were determined by enzyme-linked immunosorbent assay. The concentration of bevacizumab in rabbit vitreous after bolus injection was simulated by one-compartment first order elimination model. A transparent gel was seen in the vitreous after injection. BIO images, ERG, and histology showed that the gel does not induce hemorrhage, retinal detachment, inflammation, or other gross pathological changes in rabbit eyes after injection. While the bolus intravitreal injected bevacizumab follows the first orde...Continue Reading

References

Jul 1, 1972·American Journal of Ophthalmology·T Lawwill
Sep 1, 1984·Experimental Eye Research·B Jacobson
Dec 1, 1996·Current Eye Research·D M SchwartzR Stern
Aug 26, 1999·International Journal of Pharmaceutics·W Wang
Jun 24, 2006·Biomaterials·Stéphane G Lévesque, Molly S Shoichet
May 1, 2007·Ophthalmology·Sophie J BakriRavinder J Singh
May 24, 2008·Eye·D J Pieramici, M D Rabena
Aug 12, 2008·Current Pharmaceutical Biotechnology·Endre A Balazs
Mar 28, 2009·Investigative Ophthalmology & Visual Science·Hiroyuki NomotoTetsuya Baba
Apr 9, 2010·Current Opinion in Ophthalmology·Kapil M Sampat, Sunir J Garg
Jun 2, 2011·Clinical Ophthalmology·Christos I SinapisDespoina Perrea
Dec 27, 2011·Investigative Ophthalmology & Visual Science·Charlotte SchrammPeter Szurman
Jun 16, 2012·Nature Reviews. Drug Discovery·Kang ZhangRobert N Weinreb
Jun 6, 2013·Molecular Pharmaceutics·Puneet TyagiUday B Kompella
Jun 12, 2013·International Journal of Biological Macromolecules·Xu XuHao Chen
Nov 14, 2013·Expert Opinion on Drug Delivery·Stephen G SchwartzMichael W Stewart
Dec 29, 2013·Investigative Ophthalmology & Visual Science·Britta M RauckYadong Wang

❮ Previous
Next ❯

Citations

Aug 9, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Susanne KirchhofFerdinand P Brandl
Jun 3, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Susanne KirchhofFerdinand P Brandl
Nov 8, 2016·Drug Discovery Today·Krishna RadhakrishnanRupesh Agrawal
Jun 20, 2018·Artificial Cells, Nanomedicine, and Biotechnology·Muhammed AnwaryViness Pillay
May 13, 2018·Journal of Biomedical Materials Research. Part a·Kai WangZongchao Han
Dec 28, 2019·Pharmaceutics·Natallia DubashynskayaYury A Skorik
Apr 17, 2020·Critical Reviews in Analytical Chemistry·Leonardo Delello Di FilippoMarlus Chorilli
Jan 9, 2020·Recent Patents on Drug Delivery & Formulation·Srivdya GorantlaGautam Singhvi
Jul 6, 2018·Pharmaceutics·Sahar Awwad, Ukrit Angkawinitwong
Apr 9, 2020·Frontiers in Bioengineering and Biotechnology·Courtney R LynchViness Pillay
Feb 12, 2017·Nanomedicine·Rini Rachel Joseph, Subbu S Venkatraman
Feb 10, 2018·Therapeutic Delivery·Ludger M Ickenstein, Patrick Garidel
Oct 3, 2019·Journal of Drug Targeting·Danilo Costa GeraldesLaura de Oliveira-Nascimento
Feb 20, 2020·Eye·Jennifer J Kang-MielerWilliam F Mieler
Jul 31, 2020·Journal of Drug Targeting·Rohit BishtJayabalan Nirmal
Dec 6, 2017·Macromolecular Bioscience·Sahar AwwadSteve Brocchini
Oct 25, 2020·Pharmaceutics·Nkiruka IbeanuSahar Awwad
Jan 16, 2021·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Randolph D GlickmanIgor O Nasonkin
Jan 21, 2021·Pharmaceutics·Hyeong Min Kim, Se Joon Woo
Mar 12, 2021·Pharmacology Research & Perspectives·María L FormicaSantiago D Palma
May 24, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sahar AwwadSteve Brocchini
Jan 18, 2018·Advanced Drug Delivery Reviews·Abhirup MandalAshim K Mitra
Apr 18, 2021·Pflügers Archiv : European journal of physiology·Soumyaparna DasFrançois Paquet-Durand
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wan-Hsin ChangYuan-Hao Howard Hsu
Apr 30, 2021·Carbohydrate Polymers·Xiaodan ZhangQiang Zhu
Jul 14, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Shambhavi BagewadiAnuradha Subramanian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.